|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-7-9
|
|
pubmed:abstractText |
The HIV-1 protease mutation I50 L causes atazanavir resistance but increases susceptibility to other PIs. Predicted phenotypic FC values were obtained from viral genotypes, using the virtual Phenotype-LM bioinformatics tool (powering vircoTYPE).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1386-6532
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
405-8
|
|
pubmed:meshHeading |
pubmed-meshheading:18472298-Amino Acid Substitution,
pubmed-meshheading:18472298-Databases, Nucleic Acid,
pubmed-meshheading:18472298-Drug Resistance, Viral,
pubmed-meshheading:18472298-HIV Protease,
pubmed-meshheading:18472298-HIV Protease Inhibitors,
pubmed-meshheading:18472298-HIV-1,
pubmed-meshheading:18472298-Humans,
pubmed-meshheading:18472298-Mutation, Missense,
pubmed-meshheading:18472298-Oligopeptides,
pubmed-meshheading:18472298-Pyridines,
pubmed-meshheading:18472298-Software
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The HIV-1 protease resistance mutation I50L is associated with resistance to atazanavir and susceptibility to other protease inhibitors in multiple mutational contexts.
|
|
pubmed:affiliation |
VircoLab Inc., Durham, NC 27713, USA. psista@vrcus.jnj.com
|
|
pubmed:publicationType |
Journal Article
|
